1. Home
  2. RVTY

as of 12-12-2025 3:41pm EST

$100.25
$3.67
-3.53%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Chart Type:
Time Range:
Founded: 1937 Country:
United States
United States
Employees: N/A City: WALTHAM
Market Cap: 9.9B IPO Year: N/A
Target Price: $112.31 AVG Volume (30 days): 1.7M
Analyst Decision: Buy Number of Analysts: 14
Dividend Yield:
0.28%
Dividend Payout Frequency: Quarterly
EPS: 1.99 EPS Growth: -3.35
52 Week Low/High: $81.36 - $128.28 Next Earning Date: 01-30-2026
Revenue: $2,813,367,000 Revenue Growth: 3.37%
Revenue Growth (this year): 5.33% Revenue Growth (next year): 3.07%

AI-Powered RVTY Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 68.63%
68.63%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: